Where does Biomet Biologics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biomet Biologics, LLC ranks #5,263 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biomet Biologics, LLC hold?

Biomet Biologics, LLC holds 65 US utility patents granted between 2015 and 2021, spanning 27 technology areas.

What is Biomet Biologics, LLC's Innovation Score?

Biomet Biologics, LLC has an Innovation Score of 44.2 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Biomet Biologics, LLC's patent grant rate increasing or decreasing?

Biomet Biologics, LLC's recent grant velocity is -93% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biomet Biologics, LLC's patents?

Biomet Biologics, LLC's patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biomet Biologics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet Biologics, LLC

Q: What technology areas does Biomet Biologics, LLC focus on?

Biomet Biologics, LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 37 patents, ranking #198 of 3,490 assignees active in that subclass. Grants appear in 27 CPC subclasses total.

USPTO PatentsView assignee record - 65 granted patents across 27 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomet ranks #5,263 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 27 technology areas.

#5,263
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.2/100): 19.0
avg claims per patent: -93%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5263 · US Corporation #5,263 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,263/49,997
PHOTO-FINISH Anthony
CPC-FOCUS A61M · 27 areas
INNOV-PAR 44.2/100
CLAIMS-RICH 19.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -93% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anthony, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomet’s 44.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.5 pts (33%) Velocity 0.0 pts (0%) Breadth 18.4 pts (42%) Claim depth 11.4 pts (26%)

Qualcomm Incorporated · highest

85
Axsome Therapeutics · near

44
Biomet Biologics · this assignee

44
Decision Sciences… · near

44
Gibbs · near

44
Mitek Systems · near

44
3D Lighting… · lowest

7

What this shows Biomet's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomet?

Each dot is one of Biomet’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomet’s own 19.0 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomet vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomet's grants concentrate

Biomet Biologics, LLC is a focused PatentsView assignee: 27 CPC subclasses with 56.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (19 grants) versus a trough of 2 in 2020. By volume, Biomet sits between AZ Electronic Materials (Luxembourg) S.A.R.L. and Croda International PLC.

AZ Materials (Lux…

65
Anthony

65
Buerkert Werke

65
Bystronic Laser

65
Blue Origin

65
Bridgestone Bandag

65
Consejo Nacional…

65
Croda Internation…

65
Biomet Biologics ◀

65

What this shows Biomet holds 65 patents at rank #5,265, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biomet

By rank, the assignees closest to #5,265 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Biomet's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biomet, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Biomet ranks #198 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Mitek Systems, Inc. 44 Axsome Therapeutics, Inc. 44 Decision Sciences International Corporation 44 Gibbs Technologies Limited 44

Similar claim depth

Nearest assignees by average claims per patent (19.0 here).

C/HCA, Inc. 19.0 avg Proteus Digital Health, Inc. 19.0 avg Hobart Brothers LLC 19.0 avg Synergy Blue, LLC 19.0 avg

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biomet Biologics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	27.7%
2016	7	10.8%
2017	19	29.2%
2018	13	20.0%
2019	4	6.2%
2020	2	3.1%
2021	2	3.1%

Which technologies does Biomet Biologics, LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 37

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 31

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 26

B01D - Separation 24

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A61B - DIAGNOSIS; SURGERY; Identification 7

B04B - Centrifuges 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

C07K - Peptides 4

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

Y10T - Technical Subjects Covered BY Former US Classification 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

Top 15 of 27 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biomet Biologics, LLC's patent record in context - here's where to go next.

Biomet Biologics, LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 56.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #5,263 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biomet Biologics, LLC against AZ Electronic Materials (Luxembourg) S.A.R.L., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.